Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone

References

• Anon1999Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study GroupArch Ophthalmol11713294510532441
   PubMedGoogle Scholar
• AugustinAJSchmidt-ErfurthU2006aVerteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degenerationAm J Ophthalmol14163845
   PubMed Web of Science ®Google Scholar
• AugustinAJSchmidt-ErfurthU2006bVerteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degenerationOphthalmology1131422
   PubMed Web of Science ®Google Scholar
• AveryRLPieramiciDJRabenaMD2006Intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmology11336372 e516458968
   PubMed Web of Science ®Google Scholar
• BlumenkranzMSBresslerNMBresslerSB2002Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group. Verteporfin Therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials – TAP Report no. 5Arch Ophthalmol12013071412365909
   PubMed Web of Science ®Google Scholar
• BresslerNM2001Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2Arch Ophthalmol11919820711176980
   PubMed Web of Science ®Google Scholar
• BrownMMBrownGCSteinJD2005Age-related macular degeneration: economic burden and value-based medicine analysisCan J Ophthalmol402778715947797
   PubMed Web of Science ®Google Scholar
• ChanWMLaiTYWongAL2006Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative studyBr J Ophthalmol903374116488958
   PubMed Web of Science ®Google Scholar
• ChylackLTWolfeJKSingerDM1993The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study GroupArch Ophthalmol11183168512486
   PubMed Web of Science ®Google Scholar
• DhallaMSShahGKBlinderKJ2006Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degenerationRetina269889317151484
   PubMed Web of Science ®Google Scholar
• DweikRALewisMKavuruM1997Inhaled corticosteroids and beta-agonist inhibit oxidant production by bronchoalveolar lavage cells from normal volunteers in vivoImmunopharmacology3716369403334
   PubMed Web of Science ®Google Scholar
• GilliesMCSimpsonJMBillsonFA2004Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trialArch Ophthalmol1223364015006845
   PubMed Web of Science ®Google Scholar
• GragoudasESAdamisAPCunninghamET2004Pegaptanib for Neovascular Age-Related Macular Degeneration. for the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial GroupN Engl J Med35128051615625332
   PubMed Web of Science ®Google Scholar
• HeierJSBoyerDSCiullaTA2006Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS StudyArch Ophthalmol12415324217101999
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigIHuggerP2003Intravitreal triamcinolone acetonide for exudative age related macular degenerationBr J Ophthalmol87462812642311
   PubMed Web of Science ®Google Scholar
• KijlstraALa HeijEHendrikseF2005Immunological factors in the pathogenesis and treatment of age-related macular degenerationOcul Immunol Inflamm1331115804763
   PubMed Web of Science ®Google Scholar
• KimIKHusainDMichaudN2006Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroidInvest Ophthalmol Vis Sci473576316384985
   PubMed Web of Science ®Google Scholar
• LuttrullJKSpinkCJ2007Prolongation of choroidal hypofluorescence following combined verteporfin photodynamic therapy and intravitreal triamcinolone acetonide injectionRetina276889217621176
   PubMed Web of Science ®Google Scholar
• MeadsCHydeC2004Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic reviewBr J Ophthalmol882121714736777
   PubMed Web of Science ®Google Scholar
• MichelsSSchmidt-ErfurthU2003Sequence of early vascular events after photodynamic therapyInvest Ophthalmol Vis Sci4421475412714655
   PubMed Web of Science ®Google Scholar
• MillerJWWalshAWKramerM1995Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrinArch Ophthalmol113810187540388
   PubMed Web of Science ®Google Scholar
• NicoloMGhiglioneDLaiS2006Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfinRetina26586416395140
   PubMed Web of Science ®Google Scholar
• PeymanGAKaziAAUnalM2000Problems with and pitfalls of photodynamic therapyOphthalmology107293510647715
   PubMed Web of Science ®Google Scholar
• RechtmanEDanisRPPrattLM2004Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degenerationBr J Ophthalmol88344714977766
   PubMed Web of Science ®Google Scholar
• ReinkeMHCankisCHusainD1999Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkeyOphthalmology10619152310519585
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJS2006Ranibizumab for neovascular age-related macular degenerationN Engl J Med35514193117021318
   PubMed Web of Science ®Google Scholar
• RosenfeldPJRichRMLalwaniGA2006Ranibizumab: Phase III clinical trial resultsOphthalmol Clin North Am193617216935211
   PubMedGoogle Scholar
• Ruiz-MorenoJMMonteroJAArtolaA2005Anterior chamber transit of triamcinolone after intravitreal injectionArch Ophthalmol1231293015642842
   PubMedGoogle Scholar
• Ruiz-MorenoJMMonteroJABarileS2006aTriamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhageEur J Ophthalmol1642634
   PubMed Web of Science ®Google Scholar
• Ruiz-MorenoJMMonteroJABarileS2006bPhotodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcomeRetina2660212
   PubMed Web of Science ®Google Scholar
• Ruiz-MorenoJMMonteroJAZarbinMA2007Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcomeRetina274586117420698
   PubMed Web of Science ®Google Scholar
• Schmidt-ErfurthUMElsnerHTeraiN2004Effects of verteporfin therapy on central visual field functionOphthalmology111931915121371
   PubMed Web of Science ®Google Scholar
• SharmaSBrownGCBrownMM2001The cost-effectiveness of Photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degenerationOphthalmology1082051911713079
   PubMed Web of Science ®Google Scholar
• SpaideRFSorensonJMarananL2003Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology11015172512917166
   PubMed Web of Science ®Google Scholar
• SpaideRFSorensonJMarananL2005Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularizationOphthalmology112301415691567
   PubMed Web of Science ®Google Scholar
• TanoYChandlerDMachemerR1980Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonideAm J Ophthalmol90810167446668
   PubMed Web of Science ®Google Scholar
• TatarOAdamAShinodaK2006Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapyAm J Ophthalmol1429510416815256
   PubMed Web of Science ®Google Scholar
• WangYSFriedrichsUEichlerW2002Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cellsGraefes Arch Clin Exp Ophthalmol24042811954780
   PubMed Web of Science ®Google Scholar
• WeishauptKGomerCDoughertyT1976Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of murine tumorCancer Res36232691277137
   PubMed Web of Science ®Google Scholar